Golestan cohort study of oesophageal cancer: feasibility and first results

A Pourshams, M Saadatian-Elahi, M Nouraie, A F Malekshah, N Rakhshani, R Salahi, A Yoonessi, S Semnani, F Islami, M Sotoudeh, S Fahimi, A R Sadjadi, D Nasrollahzadeh, K Aghcheli, F Kamangar, C C Abnet, F Saidi, V Sewram, P T Strickland, S M Dawsey, P Brennan, P Boffetta, R Malekzadeh, A Pourshams, M Saadatian-Elahi, M Nouraie, A F Malekshah, N Rakhshani, R Salahi, A Yoonessi, S Semnani, F Islami, M Sotoudeh, S Fahimi, A R Sadjadi, D Nasrollahzadeh, K Aghcheli, F Kamangar, C C Abnet, F Saidi, V Sewram, P T Strickland, S M Dawsey, P Brennan, P Boffetta, R Malekzadeh

Abstract

To investigate the incidence of oesophageal cancer (EC) in the Golestan province of North-East Iran, we invited 1349 rural and urban inhabitants of Golestan province aged 35-80 to undergo extensive lifestyle interviews and to provide biological samples. The interview was repeated on a subset of 130 participants to assess reliability of questionnaire and medical information. Temperature at which tea was consumed was measured on two occasions by 110 subjects. Samples of rice, wheat and sorghum were tested for fumonisin contamination. An active follow-up was carried out after 6 and 12 months. A total of 1057 subjects (610 women and 447 men) participated in this feasibility study (78.4% participation rate). Cigarette smoking, opium and alcohol use were reported by 163 (13.8%), 93 (8.8%) and 39 (3.7%) subjects, respectively. Tobacco smoking was correlated with urinary cotinine (kappa = 0.74). Most questionnaire data had kappa > 0.7 in repeat measurements; tea temperature measurement was reliable (kappa = 0.71). No fumonisins were detected in the samples analysed. During the follow-up six subjects were lost (0.6%), two subjects developed EC (one dead, one alive); in all, 13 subjects died (with cause of death known for 11, 84.6%). Conducting a cohort study in Golestan is feasible with reliable information obtained for suspected risk factors; participants can be followed up for EC incidence and mortality.

References

    1. Abnet CC, Borkowf CB, Qiao YL, Albert PS, Wang E, Merrill Jr AH, Mark SD, Dong ZW, Taylor PR, Dawsey SM (2001a) Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china. Cancer Causes Control 12: 821–828
    1. Abnet CC, Qiao YL, Mark SD, Dong ZW, Taylor PR, Dawsey SM (2001b) Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control 12: 847–854
    1. Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, Taylor PR, Kamangar F, Dawsey SM, Malekzadeh R (2004) Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev 13: 1068–1070
    1. Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Rolon PA (2000) Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int J Cancer 88(4): 658–664
    1. Cook-Mozaffari PJ, Azordegan F, Day NE, Ressicaud A, Sabai C, Aramesh B (1979) Oesophageal cancer studies in the Caspian Littoral of Iran: results of a case–control study. Br J Cancer 39: 293–309
    1. Dowlatshahi K, Miller RJ (1985) Role of opium in esophageal cancer: a hypothesis. Cancer Res 45: 1906–1907
    1. Friesen M, O'Neill IK, Malaveille C, Garren L, Hautefeuille A, Bartsch H (1987) Substituted hydroxyphenanthrenes in opium pyrolysates implicated in oesophageal cancer in Iran: structures and in vitro metabolic activation of a novel class of mutagens. Carcinogenesis 8: 1423–1432
    1. Friesen M, O'Neill IK, Malaveille C, Garren L, Hautefeuille A, Cabral JR, Galendo D, Lasne C, Sala M, Chouroulinkov I (1985) Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutat Res 150: 177–191
    1. Ghadirian P (1987) Thermal irritation and esophageal cancer in northern Iran. Cancer 60: 1909–1914
    1. Ghadirian P, Stein GF, Gorodetzky C, Roberfroid MB, Mahon GA, Bartsch H, Day NE (1985) Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor. Int J Cancer 35: 593–597
    1. Hewer T, Rose E, Ghadirian P, Castegnaro M, Malaveille C, Bartsch H, Day N (1978) Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet 2: 494–496
    1. Ho KY, Kang JY, Seow A (1998) Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 93(10): 1816–1822
    1. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, Marjani HA, Merat S, Nasseri-Moghaddam S, Pourshams A, Nouraie M, Khatibian M, Abedi B, Brazandeh MH, Ghaziani R, Sotoudeh M, Dawsey SM, Abnet CC, Taylor PR, Malekzadeh R (2004) Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 90: 1402–1406
    1. Joint Iran-International Agency for Research on Cancer Study Group (1977) Esophageal cancer studies in the Caspian littoral of Iran: results of population studies – a prodrome. J Natl Cancer Inst 59: 1127–1138
    1. Kmet J, Mahboubi E (1972) Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 175: 846–853
    1. Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S (1973) Oesophageal cancer studies in the Caspian littoral of Iran: the Caspian cancer registry. Br J Cancer 28: 197–214
    1. Malaveille C, Friesen M, Camus AM, Garren L, Hautefeuille A, Bereziat JC, Ghadirian P, Day NE, Bartsch H (1982) Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus. Carcinogenesis 3: 577–585
    1. Munoz N, Day NE (1996) Esophageal cancer. In Cancer Epidemiology and Prevention Schottenfeld D, Fraumeni JF (eds). pp 681–706. New York: Oxford University Press
    1. Nair J, Havovi S, Chakradeo P, Jakhi SA, Bhide SV (1992) Effect of oral hygiene on nitrosamine formation in the mouth. In Nitroso Compounds: Biological Mechanisms, Exposure and Cancer Etiology O'Neill IK, Bartsch H (eds). Lyon: International Agency for Research on Cancer
    1. Onuk MD, Oztopuz A, Memik F (2002) Risk factors for esophageal cancer in eastern Anatolia. Hepatogastroenterology 49: 1290–1292
    1. Ribeiro Pinto LF, Swann PF (1997) Opium and oesophageal cancer: effect of morphine and opium on the metabolism of N-nitrosodimethylamine and N-nitrosodiethylamine in the rat. Carcinogenesis 18: 365–369
    1. Sewram V, De Stefani E, Brennan P, Boffetta P (2003) Mate consumption and the risk of squamous cell esophageal cancer in Uruguay. Cancer Epidemiol Biomarkers Prev 12: 508–513
    1. Sharp L, Chilvers CE, Cheng KK, McKinney PA, Logan RF, Cook-Mozaffari P, Ahmed A, Day NE (2001) Risk factors for squamous cell carcinoma of the oesophagus in women: a case–control study. Br J Cancer 85(11): 1667–1670
    1. Shephard GS, Marasas WF, Yazdanpanah H, Rahimian H, Safavi N, Zarghi A, Shafaati A, Rasekh HR (2002) Fumonisin B(1) in maize harvested in Iran during 1999. Food Addit Contam 19: 676–679
    1. Sydenham EW, Shephard GS, Thiel PG, Stockenström S, Snijman PW (1996) Liquid chromatographic determination of fumonisins B1, B2, and B3 in corn: AOAC-IUPAC Collaborative Study. J AOAC Int 79: 688–696
    1. Wang H, Wei H, Ma J, Luo X (2000) The fumonisin B1 content in corn from North China, a high-risk area of esophageal cancer. J Environ Pathol Toxicol Oncol 19: 139–141
    1. White E, Hunt JR, Casso D (1998) Exposure measurement in cohort studies: the challenges of prospective data collection. Epidemiol Rev 20: 43–56

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다